Silver Book Fact

AFib, an economic burden

Fact image

AFib is a major economic burden for the U.S. with at least $6.65 billion in healthcare costs attributable to the disease each year. This estimate may be low. One study estimates that Medicare alone pays $15.7 billion per year to treat newly diagnosed AFib patients.

Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective. J Med Econ. 2008; 11(2). http://www.ncbi.nlm.nih.gov/pubmed/19450086

Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States. Value in Health. 2006; 9(5). http://www.ncbi.nlm.nih.gov/pubmed/16961553

Reference

Title
Direct Treatment Cost of Atrial Fibrillation in the Elderly American Population: A Medicare perspective
Publication
J Med Econ
Publication Date
2008
Volume & Issue
Volume 11, Issue 2
Pages
281-98
URL
Read Full Resource
Title
Assessing the Direct Costs of Treating Nonvalvular Atrial Fibrillation in the United States
Publication
Value in Health
Publication Date
2006
Volume & Issue
Volume 9, Issue 5
Pages
348-56
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Atrial fibrillation prevalence, 2007
    An estimated 2.2 million Americans have atrial fibrillation and most are over the age of 65.  
  • Annual cost of AFib-related stroke in Medicare patients
    The annual cost of stroke in Medicare patients with atrial fibrillation is estimated at $8 billion.  
  • The heart can beat upwards of 175 times or more per minute during an AFib episode.  
  • Average length of stay for major bleeding complications
    The average length of stay for major bleeding complications is six days.  
  • AFib-related stroke and disability
    Stroke is very disabling and individuals recovering from a stroke who also have AFib have a higher risk of remaining disable or handicapped compared to stroke patients without AFib.